Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Scotlandi

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
International Journal of Oncology|January 26, 1999
Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcomaM Serra, D Maurici, K Scotlandi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 17, 2001
Simultaneous paired analysis of numerical chromosomal aberrations and DNA content in osteosarcomaM Serra, M Tarkkanen, N Baldini, et al.
Human Pathology|December 1, 1992
Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumorsM Serra, M C Morini, K Scotlandi, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|April 8, 2006
Anticancer effects of zoledronic acid against human osteosarcoma cellsB Kubista, K Trieb, F Sevelda, et al.
Bone|March 10, 2000
Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase geneM C Manara, N Baldini, M Serra, et al.
International Journal of Cancer|June 22, 2000
Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cellsC Ricci, L Landuzzi, I Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcomaI Scionti, F Michelacci, M Pasello, et al.
International Journal of Oncology|November 8, 2005
The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71M C Manara, S Perdichizzi, M Serra, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1989
In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent findingG Nicoletti, C de Giovanni, P L Lollini, et al.
Oncogene|April 18, 1996
Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomasR Ferracini, M Olivero, M F Di Renzo, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Oncology|January 26, 1999
Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcomaM Serra, D Maurici, K Scotlandi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 17, 2001
Simultaneous paired analysis of numerical chromosomal aberrations and DNA content in osteosarcomaM Serra, M Tarkkanen, N Baldini, et al.
Human Pathology|December 1, 1992
Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumorsM Serra, M C Morini, K Scotlandi, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|April 8, 2006
Anticancer effects of zoledronic acid against human osteosarcoma cellsB Kubista, K Trieb, F Sevelda, et al.
Bone|March 10, 2000
Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase geneM C Manara, N Baldini, M Serra, et al.
International Journal of Cancer|June 22, 2000
Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cellsC Ricci, L Landuzzi, I Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcomaI Scionti, F Michelacci, M Pasello, et al.
International Journal of Oncology|November 8, 2005
The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71M C Manara, S Perdichizzi, M Serra, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1989
In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent findingG Nicoletti, C de Giovanni, P L Lollini, et al.
Oncogene|April 18, 1996
Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomasR Ferracini, M Olivero, M F Di Renzo, et al.
Pageof 9